Tuesday, October 13, 2015 9:45:01 PM
Someone knows something, but no one is talking.
Images
What: Zafgen (NASDAQ:ZFGN) fell 29% today giving it a two-day loss of a whopping 54%. As best anyone can tell, the decline started yesterday when investors learned the company cancelled some meetings it had with investors.
ZFGN Price Chart
ZFGN Price data by YCharts
So what: There are a lot of possibilities for why a company would cancel meetings with investors -- maybe the CEO got the flu? -- but given the radio silence from management while its stock is in freefall, it seems likely that the company's lawyers have ordered a quiet period.
Zafgen has a couple of clinical trials under way testing its lead drug, beloranib, in a genetic disease called Prader-Willi Syndrome that causes patient to have a chronic feeling of hunger and another in severe obesity. The quiet period could be because the company has good news or bad news from the clinical trials or potentially other news -- acquisition, management changes, etc.
Investors are clearly betting on bad news. It's possible that bad news was leaked, causing investors in the know to sell. It's also possible that investors are worried that someone else knows something -- even if no one knows anything -- and then the selling just reinforces investors' hunches that someone knows something.
Now what: I don't have any more information than any other investors. But here are some points to consider:
Positive efficacy data would require more time to work through than negative safety data.
Negative efficacy data can theoretically be presented as quickly as negative safety data, but companies sometimes data mine to try and find something positive to say about a negative clinical trial.
The longer this goes on, the less likely the issue is an acquisition or management change, which could be resolved and/or commented on -- even if it's "no comment" -- in a timely manner.
Buying Zafgen at this point will result in a substantial gain if the news turns out to be positive, but without any inside knowledge of the news, it would be more of a wager than an actual investment.
http://www.fool.com/investing/general/2015/10/13/why-zafgen-is-down-54-over-the-last-two-days.aspx?source=eogyholnk0000001&utm_source=yahoo&utm_medium=feed&utm_campaign=article
Recent LRMR News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 10:05:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:57:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:56:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:07:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:08:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/28/2024 04:15:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:08:07 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/09/2024 08:50:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:02:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:09:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:06:02 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:57:52 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 10:08:46 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 01:55:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 11:06:09 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2024 09:46:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 12:03:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:33:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:32:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:08:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:51:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:23 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM